KNBIF (Kane Biotech) FCF Yield %: -43.48 (As of Jun. 24, 2026)


What is Kane Biotech FCF Yield %?

Kane Biotech KNBIF +5.19% FCF Yield % is -43.48 as of Jun. 24, 2026. The stock has 6 warning signs investors should review. Among 1,417 Biotechnology companies, Kane Biotech ranks worse than 81.58% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Kane Biotech's Trailing 12-Month Free Cash Flow is $-1.99 Mil, and Market Cap is $4.35 Mil. Therefore, Kane Biotech's FCF Yield % for today is -43.48%.

The historical rank and industry rank for Kane Biotech's FCF Yield % or its related term are showing as below:

KNBIF' s FCF Yield % Range Over the Past 10 Years
Min: -71.53   Med: -25.59   Max: -2.67
Current: -43.48

During the past 13 years, the highest FCF Yield % of Kane Biotech was -2.67%. The lowest was -71.53%. And the median was -25.59%.

KNBIF's FCF Yield % is ranked worse than
81.58% of 1417 companies
in the Biotechnology industry
Industry Median: -9.7 vs KNBIF: -43.48

Kane Biotech's FCF Margin % for the quarter that ended in Mar. 2026 was -1,170.97%.

Kane Biotech FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Kane Biotech FCF Yield % Related Terms

Kane Biotech FCF Yield % Historical Data

* Premium members only.

The historical data trend for Kane Biotech's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kane Biotech FCF Yield % Chart

Kane Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -14.54 -30.71 -19.69 -27.80 -50.55

Kane Biotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -30.86 -41.55 -37.09 -42.23 -36.29

KNBIF vs VRTX, REGN, ALNY: FCF Yield % Comparison

For the Biotechnology subindustry, Kane Biotech's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kane Biotech FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kane Biotech's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Kane Biotech's FCF Yield % falls into.


Kane Biotech FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Kane Biotech's FCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-2.442 / 4.8304802
=-50.55%

Kane Biotech's annualized FCF Yield % for the quarter that ended in Mar. 2026 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.363 * 4 / 4.000854
=-36.29%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -43.48 mean?
Kane Biotech (KNBIF) has a FCF Yield % of -43.48 as of Jun. 24, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Kane Biotech and its competitors. According to the industry distribution chart, Kane Biotech ranks #1156 out of 1417 companies in the Biotechnology industry, placing it in the top 81.6%.
Is Kane Biotech's FCF Yield % too high?
Kane Biotech's current FCF Yield % is -43.48. Based on the distribution chart, Kane Biotech ranks #1156 out of 1417 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Kane Biotech's FCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Kane Biotech ranks #1156 out of 1417 companies for FCF Yield %. This places Kane Biotech in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Kane Biotech and its competitors. Kane Biotech's current FCF Yield % is -43.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kane Biotech stock overvalued right now?
Kane Biotech (KNBIF) has a current FCF Yield % of -43.48. The current FCF Yield % is -43.48. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Kane Biotech (KNBIF), the current FCF Yield % is -43.48 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kane Biotech Business Description

Other Exchanges KNE:Canada
Address 290-100 Innovation Drive, Winnipeg, MB, CAN, R3T 6G2
Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise and acquired from research institutions. The company's operating segments are animal health and human health. It derives maximum revenue from Animal health segment.